A review of clinical studies on off-label use of rituximab in China

doi:10.3969/j.issn.1672-3384.2024.09.002

PDF(741 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (9) : 24-29. DOI: 10.3969/j.issn.1672-3384.2024.09.002

Review

A review of clinical studies on off-label use of rituximab in China

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(9): 24-29 https://doi.org/10.3969/j.issn.1672-3384.2024.09.002

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(741 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2024-08-13	2024-09-20
Issue Date
2024-11-06

Please choose a citation manager

Content to export